Skip to content

Treatment of Wounds Utilizing Light

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00634868
Enrollment
30
Registered
2008-03-13
Start date
2008-08-31
Completion date
2010-12-31
Last updated
2011-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Ulcer

Keywords

ulcer wound diabetes

Brief summary

The Qray device is emitting broad light energy that is intended for diabetic ulcer healing. The study is double blinded.

Interventions

OTHERQray light therapy device

The light is filtered from harmful UV and InfraRed light and only light at wavelight of 405nm until 1000nm is delivered.

DEVICEQray light therapy device-Sham

non curative light- the device emits the same broad light, but with very low intensity

Sponsors

QRay Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient has 8 weeks venus leg ulcer. * The ulcer was not better on prior treatment of various medical clinics. * The patient has diabetic ulcer grade 1 or 2

Exclusion criteria

* Patient has severe infection. * Patient is taking antibiotic * Patient has ankle brachial index less than 0.7 * Patient is schedule to undergone revascularization surgery 10 weeks before the study * Patient has photosensitive disease * Patient has cancer * Creatinine level is more than 2 mg% * Patient is taking immunosuppressive medication. * Pregnant women * Dialysis patient * Anaemic patients(less than 9 gr) * Patient has Albumin level less than 3 mg%

Design outcomes

Primary

MeasureTime frame
The wound healing process12 weeks

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026